CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:An injectable hydrogel microsphere-integrated training court to inspire tumor-infiltrating T lymphocyte potential.
An injectable hydrogel microsphere-integrated training court to inspire tumor-infiltrating T lymphocyte potential.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
尽管肿瘤浸润性T淋巴细胞(TIL-Ts)在实体瘤免疫治疗中发挥着关键作用,但其临床应用因免疫抑制性微环境而受到限制。在此,我们开发了一种可注射的水凝胶微球集成训练场(MS-ITC),通过接枝抗CD3和抗CD28抗体以及包载IL-7和IL-15的牛血清白蛋白纳米颗粒,来激发TIL-Ts的功能并扩增TIL-Ts。MS-ITC提供了TIL-Ts活化所需的T细胞受体和共刺激信号,以及用于TIL-Ts扩增的IL-7/IL-15信号。随后,将MS-ITC局部注射到小鼠骨肉瘤肿瘤组织中。MS-ITC对原发性骨肉瘤生长的抑制超过95%,同时肿瘤组织中的TIL-Ts被激活并扩增,CD8+ T细胞和记忆T细胞显著增加,从而增强了抗肿瘤效果。总之,这项工作提供了一种可注射的水凝胶微球集成训练平台,能够激发TIL-Ts在一系列实体瘤免疫治疗中的潜力。
Although tumor-infiltrating T lymphocytes (TIL-Ts) play a crucial role in solid tumor immunotherapy, their clinical application has been limited because of the immunosuppressive microenvironment.
Herein, we developed an injectable hydrogel microsphere-integrated training court (MS-ITC) to inspire the function of TIL-Ts and amplify TIL-Ts, through grafting with anti-CD3 and anti-CD28 antibodies and bovine serum albumin nanoparticles encapsulated with IL-7 and IL-15. MS-ITC provided the T-cell receptor and co-stimulatory signals required for TIL-Ts activation and IL-7/IL-15 signals for TIL-Ts expansion.
Afterward, the MS-ITC was injected locally into the osteosarcoma tumor tissue in mice. MS-ITC suppressed the growth of primary osteosarcoma by more than 95 %, accompanied with primed and expanded TIL-Ts in the tumor tissues, compromising significantly increased CD8 + T and memory T cells, thereby enhancing the anti-tumor effect.
Together, this work provides an injectable hydrogel microsphere-integrated training platform capable of inspiring TIL-Ts potential for a range of solid tumor immunotherapy.
MEMBER ACCOUNT
登录成功会直接打开下一页。